chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site urticaria
Clinical narrative: chills; growing in redness on upper arm; some itchy feeling at times; feels like there is a hard welt or something underneath the skin; feels like there is a hard welt or something underneath the skin; red circle around the injection site on left arm; its kinda sore; joint pain; muscle pain; fatigued; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (growing in redness on upper arm), PRURITUS (some itchy feeling at times), VACCINATION SITE URTICARIA (feels like there is a hard welt or something underneath the skin), VACCINATION SITE INDURATION (feels like there is a hard welt or something underneath the skin) and VACCINATION SITE ERYTHEMA (red circle around the injection site on left arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included BENAZEPRIL, VITAMIN C;VITAMIN D NOS;VITAMIN E, NORTRIPTYLINE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and SIMVASTATIN for an unknown indication.   On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced ERYTHEMA (growing in redness on upper arm), PRURITUS (some itchy feeling at times), VACCINATION SITE URTICARIA (feels like there is a hard welt or something underneath the skin), VACCINATION SITE INDURATION (feels like there is a hard welt or something underneath the skin), VACCINATION SITE ERYTHEMA (red circle around the injection site on left arm), VACCINATION SITE PAIN (its kinda sore), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and FATIGUE (fatigued). On 06-May-2021, the patient experienced CHILLS (chills). At the time of the report, ERYTHEMA (growing in redness on upper arm), PRURITUS (some itchy feeling at times), VACCINATION SITE URTICARIA (feels like there is a hard welt or something underneath the skin), VACCINATION SITE ERYTHEMA (red circle around the injection site on left arm), VACCINATION SITE PAIN (its kinda sore), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigued) and CHILLS (chills) outcome was unknown.            Treatment includes using ice packs on arm when needed. The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable, reporter didn't provide causality assessment.   This case was linked to MOD-2021-118974 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Eczema, Eye swelling, Influenza, Lip swelling, Ocular hyperaemia
Clinical narrative: Flu; completely covered in hives; eyes were swollen; red eyes; lips were swollen three times the size; eczema; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu), URTICARIA (completely covered in hives), EYE SWELLING (eyes were swollen), OCULAR HYPERAEMIA (red eyes) and LIP SWELLING (lips were swollen three times the size) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Flu), URTICARIA (completely covered in hives), EYE SWELLING (eyes were swollen), OCULAR HYPERAEMIA (red eyes), LIP SWELLING (lips were swollen three times the size) and ECZEMA (eczema). At the time of the report, INFLUENZA (Flu), URTICARIA (completely covered in hives), EYE SWELLING (eyes were swollen), OCULAR HYPERAEMIA (red eyes), LIP SWELLING (lips were swollen three times the size) and ECZEMA (eczema) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment taken was cortisone cream and anti-histamine
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Flu; completely covered in hives; eyes were swollen; red eyes; lips were swollen three times the size; eczema; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu), URTICARIA (completely covered in hives), EYE SWELLING (eyes were swollen), OCULAR HYPERAEMIA (red eyes) and LIP SWELLING (lips were swollen three times the size) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Flu), URTICARIA (completely covered in hives), EYE SWELLING (eyes were swollen), OCULAR HYPERAEMIA (red eyes), LIP SWELLING (lips were swollen three times the size) and ECZEMA (eczema). At the time of the report, INFLUENZA (Flu), URTICARIA (completely covered in hives), EYE SWELLING (eyes were swollen), OCULAR HYPERAEMIA (red eyes), LIP SWELLING (lips were swollen three times the size) and ECZEMA (eczema) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment taken was cortisone cream and anti-histamine
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Frustration tolerance decreased, Menstrual disorder, Menstruation irregular, Myalgia, Ovulation disorder
Clinical narrative: frustration; missed, irregular period; does not feel anything anymore when she is ovulating; light menstrual flow than the usual; sore arms/body aches; fever of 101 degrees Fahrenheit; This spontaneous case was reported by a health care professional and describes the occurrence of MENSTRUAL DISORDER (light menstrual flow than the usual), MENSTRUATION IRREGULAR (missed, irregular period), OVULATION DISORDER (does not feel anything anymore when she is ovulating), FRUSTRATION TOLERANCE DECREASED (frustration) and MYALGIA (sore arms/body aches) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced MYALGIA (sore arms/body aches) and PYREXIA (fever of 101 degrees Fahrenheit). On 11-Apr-2021, the patient experienced MENSTRUAL DISORDER (light menstrual flow than the usual). On 12-May-2021, the patient experienced MENSTRUATION IRREGULAR (missed, irregular period) and OVULATION DISORDER (does not feel anything anymore when she is ovulating). On an unknown date, the patient experienced FRUSTRATION TOLERANCE DECREASED (frustration). At the time of the report, MENSTRUAL DISORDER (light menstrual flow than the usual), MENSTRUATION IRREGULAR (missed, irregular period), OVULATION DISORDER (does not feel anything anymore when she is ovulating), FRUSTRATION TOLERANCE DECREASED (frustration), MYALGIA (sore arms/body aches) and PYREXIA (fever of 101 degrees Fahrenheit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: frustration; missed, irregular period; does not feel anything anymore when she is ovulating; light menstrual flow than the usual; sore arms/body aches; fever of 101 degrees Fahrenheit; This spontaneous case was reported by a health care professional and describes the occurrence of MENSTRUAL DISORDER (light menstrual flow than the usual), MENSTRUATION IRREGULAR (missed, irregular period), OVULATION DISORDER (does not feel anything anymore when she is ovulating), FRUSTRATION TOLERANCE DECREASED (frustration) and MYALGIA (sore arms/body aches) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced MYALGIA (sore arms/body aches) and PYREXIA (fever of 101 degrees Fahrenheit). On 11-Apr-2021, the patient experienced MENSTRUAL DISORDER (light menstrual flow than the usual). On 12-May-2021, the patient experienced MENSTRUATION IRREGULAR (missed, irregular period) and OVULATION DISORDER (does not feel anything anymore when she is ovulating). On an unknown date, the patient experienced FRUSTRATION TOLERANCE DECREASED (frustration). At the time of the report, MENSTRUAL DISORDER (light menstrual flow than the usual), MENSTRUATION IRREGULAR (missed, irregular period), OVULATION DISORDER (does not feel anything anymore when she is ovulating), FRUSTRATION TOLERANCE DECREASED (frustration), MYALGIA (sore arms/body aches) and PYREXIA (fever of 101 degrees Fahrenheit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Mixed Pfizer Vaccine for first dose and for the second dose Moderna; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Mixed Pfizer Vaccine for first dose and for the second dose Moderna) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Mixed Pfizer Vaccine for first dose and for the second dose Moderna). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Mixed Pfizer Vaccine for first dose and for the second dose Moderna) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Sore arm/ left arm tenderness 6 hour vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm/ left arm tenderness 6 hour vaccine) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) and VITAMINS NOS for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Sore arm/ left arm tenderness 6 hour vaccine). At the time of the report, MYALGIA (Sore arm/ left arm tenderness 6 hour vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment information provided    This case was linked to MOD-2021-119401 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: cold like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced NASOPHARYNGITIS (cold like symptoms). At the time of the report, NASOPHARYNGITIS (cold like symptoms) outcome was unknown. Not Provided          Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Feeling sick; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Feeling sick). At the time of the report, MALAISE (Feeling sick) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment Not Provided - Call Disconnected
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia, Tinnitus
Clinical narrative: Severe tinnitus in left ear; Body aches; Chills; Mild fever; Second dose severe headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Severe tinnitus in left ear), PAIN (Body aches), CHILLS (Chills), PYREXIA (Mild fever) and HEADACHE (Second dose severe headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 012L20A) for COVID-19 vaccination.     The medical history was not provided by the reporter.  Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and VITAMINS NOS for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced TINNITUS (Severe tinnitus in left ear), PAIN (Body aches), CHILLS (Chills), PYREXIA (Mild fever) and HEADACHE (Second dose severe headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 20-Feb-2021, PAIN (Body aches), CHILLS (Chills) and PYREXIA (Mild fever) had resolved. On 21-Feb-2021, HEADACHE (Second dose severe headache) had resolved. At the time of the report, TINNITUS (Severe tinnitus in left ear) had not resolved.            This case was linked to MOD-2021-119296 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymphadenopathy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymphadenopathy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Lymphadenopathy). At the time of the report, LYMPHADENOPATHY (Lymphadenopathy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: sore arm; achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and PAIN (achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and PAIN (achy). At the time of the report, PAIN IN EXTREMITY (sore arm) and PAIN (achy) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided. No treatment information provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-057817 (Linked Report). This case was linked to MOD-2021-057817; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-057817:2nd dose case
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Mild headache; Mild fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Mild headache), FATIGUE (Mild fatigue) and PYREXIA (fever) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 002A21A) for COVID-19 vaccination.     The patient's past medical history included Sinusitis since 01-Jan-2013. Concurrent medical conditions included Drug allergy (Amoxicillin), Anxiety, High cholesterol, Nausea, GERD, Depression (mild) and Drug allergy. Concomitant products included ALPRAZOLAM (XANAX) from 01-Jan-2001 to an unknown date for Anxiety, ESCITALOPRAM OXALATE (LEXAPRO) from 01-Jan-2017 to an unknown date for Depression, OMEPRAZOLE from 01-Jan-2001 to an unknown date for GERD, SIMVASTATIN from 01-Jan-2010 to an unknown date for High cholesterol, PROMETHAZINE (PHENERGAN [PROMETHAZINE]) from 01-Jan-2010 to an unknown date for Nausea.   On 08-Mar-2021 at 12:05 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021 at 2:05 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (fever). On an unknown date, the patient experienced HEADACHE (Mild headache) and FATIGUE (Mild fatigue). At the time of the report, HEADACHE (Mild headache), FATIGUE (Mild fatigue) and PYREXIA (fever) had resolved.            Patient managed symptoms with Motrin/Tylenol not specified).  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-052006 (E2B Linked Report). This case was linked to MOD-2021-051162 (Patient Link).; Sender's Comments:  MOD-2021-052006:Same reporter/unknown patients (Invalid case)
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: Red Bump; Pain on left arm when touched; Redness; Diarrhea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Red Bump), DIARRHOEA (Diarrhea), HEADACHE (Headache), VACCINATION SITE PAIN (Pain on left arm when touched) and VACCINATION SITE ERYTHEMA (Redness) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced DIARRHOEA (Diarrhea) and HEADACHE (Headache). On 10-May-2021, the patient experienced VACCINATION SITE MASS (Red Bump), VACCINATION SITE PAIN (Pain on left arm when touched) and VACCINATION SITE ERYTHEMA (Redness). On 05-May-2021, DIARRHOEA (Diarrhea) and HEADACHE (Headache) had resolved. At the time of the report, VACCINATION SITE MASS (Red Bump), VACCINATION SITE PAIN (Pain on left arm when touched) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Colonoscopy, Condition aggravated, Feeling abnormal, Feeling hot, Iron deficiency
Clinical narrative: I had exacerbation of my conditions; I feel horrible now; I feel my inner body on fire; I lost iron; colonoscopy; I got fever; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (I had exacerbation of my conditions), FEELING ABNORMAL (I feel horrible now), FEELING HOT (I feel my inner body on fire), IRON DEFICIENCY (I lost iron) and COLONOSCOPY (colonoscopy) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Kidney failure (Stage-3 kidney failure. (GFR of 23 as last reading).), Lymphedema and Face injury (Patient stated that he had, in the 1977, where a silicone filler injection was used for his face by a plastic surgeon, after a face injury back then.). Concomitant products included pain management medications, anxiety medications, ulcer medications and Blood pressure medications for an unknown indication.    On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced CONDITION AGGRAVATED (I had exacerbation of my conditions), FEELING ABNORMAL (I feel horrible now), FEELING HOT (I feel my inner body on fire), IRON DEFICIENCY (I lost iron), COLONOSCOPY (colonoscopy) and PYREXIA (I got fever). At the time of the report, CONDITION AGGRAVATED (I had exacerbation of my conditions), FEELING ABNORMAL (I feel horrible now), FEELING HOT (I feel my inner body on fire), IRON DEFICIENCY (I lost iron), COLONOSCOPY (colonoscopy) and PYREXIA (I got fever) outcome was unknown. Not Provided.         Treatment Patient did not take anything beside his pain medications that he used for other health conditions to help with side effects of the vaccine.   This case was linked to MOD-2021-081783 (Patient Link).
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: I had exacerbation of my conditions; I feel horrible now; I feel my inner body on fire; I lost iron; colonoscopy; I got fever; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (I had exacerbation of my conditions), FEELING ABNORMAL (I feel horrible now), FEELING HOT (I feel my inner body on fire), IRON DEFICIENCY (I lost iron) and COLONOSCOPY (colonoscopy) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Kidney failure (Stage-3 kidney failure. (GFR of 23 as last reading).), Lymphedema and Face injury (Patient stated that he had, in the 1977, where a silicone filler injection was used for his face by a plastic surgeon, after a face injury back then.). Concomitant products included pain management medications, anxiety medications, ulcer medications and Blood pressure medications for an unknown indication.    On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced CONDITION AGGRAVATED (I had exacerbation of my conditions), FEELING ABNORMAL (I feel horrible now), FEELING HOT (I feel my inner body on fire), IRON DEFICIENCY (I lost iron), COLONOSCOPY (colonoscopy) and PYREXIA (I got fever). At the time of the report, CONDITION AGGRAVATED (I had exacerbation of my conditions), FEELING ABNORMAL (I feel horrible now), FEELING HOT (I feel my inner body on fire), IRON DEFICIENCY (I lost iron), COLONOSCOPY (colonoscopy) and PYREXIA (I got fever) outcome was unknown. Not Provided.         Treatment Patient did not take anything beside his pain medications that he used for other health conditions to help with side effects of the vaccine.   This case was linked to MOD-2021-081783 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Injection site rash, Insomnia, Malaise
Clinical narrative: Rash on arm 3 days after vaccine; Vomiting; Could not get out of bed; Body aches; Worst migraine I've ever had; Insomnia; Extreme nausea; Felt so sick; Fever of 102; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Body aches), MIGRAINE (Worst migraine I've ever had), INSOMNIA (Insomnia), NAUSEA (Extreme nausea) and MALAISE (Felt so sick) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Peanut allergy, Food allergy (Treenuts) and Fruit allergy (Fresh fruit).   On 12-Mar-2021 at 5:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021 at 5:10 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021 at 7:00 PM, the patient experienced PAIN (Body aches), MIGRAINE (Worst migraine I've ever had), INSOMNIA (Insomnia), NAUSEA (Extreme nausea), MALAISE (Felt so sick), PYREXIA (Fever of 102), VOMITING (Vomiting) and FATIGUE (Could not get out of bed). On 12-Apr-2021, the patient experienced INJECTION SITE RASH (Rash on arm 3 days after vaccine). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form(2 days). On 11-Apr-2021, FATIGUE (Could not get out of bed) had resolved. On 17-Apr-2021, INJECTION SITE RASH (Rash on arm 3 days after vaccine) had resolved. On 25-Apr-2021, PAIN (Body aches), MIGRAINE (Worst migraine I've ever had), INSOMNIA (Insomnia), NAUSEA (Extreme nausea), MALAISE (Felt so sick), PYREXIA (Fever of 102) and VOMITING (Vomiting) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, Body temperature: 102 (High) 102.         Concomitant medications were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-054591 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054591:First dose case
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Rash on arm 3 days after vaccine; Vomiting; Could not get out of bed; Body aches; Worst migraine I've ever had; Insomnia; Extreme nausea; Felt so sick; Fever of 102; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Body aches), MIGRAINE (Worst migraine I've ever had), INSOMNIA (Insomnia), NAUSEA (Extreme nausea) and MALAISE (Felt so sick) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Peanut allergy, Food allergy (Treenuts) and Fruit allergy (Fresh fruit).   On 12-Mar-2021 at 5:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021 at 5:10 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021 at 7:00 PM, the patient experienced PAIN (Body aches), MIGRAINE (Worst migraine I've ever had), INSOMNIA (Insomnia), NAUSEA (Extreme nausea), MALAISE (Felt so sick), PYREXIA (Fever of 102), VOMITING (Vomiting) and FATIGUE (Could not get out of bed). On 12-Apr-2021, the patient experienced INJECTION SITE RASH (Rash on arm 3 days after vaccine). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form(2 days). On 11-Apr-2021, FATIGUE (Could not get out of bed) had resolved. On 17-Apr-2021, INJECTION SITE RASH (Rash on arm 3 days after vaccine) had resolved. On 25-Apr-2021, PAIN (Body aches), MIGRAINE (Worst migraine I've ever had), INSOMNIA (Insomnia), NAUSEA (Extreme nausea), MALAISE (Felt so sick), PYREXIA (Fever of 102) and VOMITING (Vomiting) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, Body temperature: 102 (High) 102.         Concomitant medications were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-054591 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054591:First dose case
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Oral contusion, Swollen tongue, Tongue blistering, Tongue discomfort
Clinical narrative: 2nd dose of vaccine was postponed for 2 more weeks a day before scheduled dose; Tongue swelled up 4 hours after vaccination; covid arm; bruised; Blistered; tongue had rubbed against her teeth/ Tongue was banging up against teeth; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of vaccine was postponed for 2 more weeks a day before scheduled dose), SWOLLEN TONGUE (Tongue swelled up 4 hours after vaccination), VACCINATION SITE REACTION (covid arm), ORAL CONTUSION (bruised) and TONGUE BLISTERING (Blistered) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of vaccine was postponed for 2 more weeks a day before scheduled dose), SWOLLEN TONGUE (Tongue swelled up 4 hours after vaccination), VACCINATION SITE REACTION (covid arm), ORAL CONTUSION (bruised), TONGUE BLISTERING (Blistered) and TONGUE DISCOMFORT (tongue had rubbed against her teeth/ Tongue was banging up against teeth). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of vaccine was postponed for 2 more weeks a day before scheduled dose) had resolved and SWOLLEN TONGUE (Tongue swelled up 4 hours after vaccination), VACCINATION SITE REACTION (covid arm), ORAL CONTUSION (bruised), TONGUE BLISTERING (Blistered) and TONGUE DISCOMFORT (tongue had rubbed against her teeth/ Tongue was banging up against teeth) outcome was unknown.            Concomitant medication was not provided Treatment medication include Benadryl and Arnica .  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.    This case was linked to MOD-2021-053378 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: 2nd dose of vaccine was postponed for 2 more weeks a day before scheduled dose; Tongue swelled up 4 hours after vaccination; covid arm; bruised; Blistered; tongue had rubbed against her teeth/ Tongue was banging up against teeth; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of vaccine was postponed for 2 more weeks a day before scheduled dose), SWOLLEN TONGUE (Tongue swelled up 4 hours after vaccination), VACCINATION SITE REACTION (covid arm), ORAL CONTUSION (bruised) and TONGUE BLISTERING (Blistered) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of vaccine was postponed for 2 more weeks a day before scheduled dose), SWOLLEN TONGUE (Tongue swelled up 4 hours after vaccination), VACCINATION SITE REACTION (covid arm), ORAL CONTUSION (bruised), TONGUE BLISTERING (Blistered) and TONGUE DISCOMFORT (tongue had rubbed against her teeth/ Tongue was banging up against teeth). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose of vaccine was postponed for 2 more weeks a day before scheduled dose) had resolved and SWOLLEN TONGUE (Tongue swelled up 4 hours after vaccination), VACCINATION SITE REACTION (covid arm), ORAL CONTUSION (bruised), TONGUE BLISTERING (Blistered) and TONGUE DISCOMFORT (tongue had rubbed against her teeth/ Tongue was banging up against teeth) outcome was unknown.            Concomitant medication was not provided Treatment medication include Benadryl and Arnica .  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.    This case was linked to MOD-2021-053378 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site feels hot; Redness at injection site; Swollen arm at injection site; Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site feels hot), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (Swollen arm at injection site) and VACCINATION SITE PAIN (Soreness at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007621A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Injection site feels hot), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (Swollen arm at injection site) and VACCINATION SITE PAIN (Soreness at injection site). On 30-Apr-2021, VACCINATION SITE SWELLING (Swollen arm at injection site) and VACCINATION SITE PAIN (Soreness at injection site) had resolved. At the time of the report, VACCINATION SITE WARMTH (Injection site feels hot) and VACCINATION SITE ERYTHEMA (Redness at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient started experiencing redness, soreness, and swelling about an inch long and wide at the injection site on 27 Apr 2021. The soreness only lasted for 3 days but her arm was still red and hot as of 11 May 2021.  Treatment medications were not reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: aches; fever; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis (had multiple sclerosis for years, though they not taking any medications for it at the time.). Concomitant products included ESTRADIOL, VITAMIN D NOS, BUPROPION, CITALOPRAM, VALACYCLOVIR [VALACICLOVIR], OXYBUTYNIN and MAGNESIUM OXIDE for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced MYALGIA (aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 04-Apr-2021, MYALGIA (aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-120216 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema
Clinical narrative: a large pink reddish rash(ring rash thing)around the injection site; tired; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-May-2021 and was forwarded to Moderna on 11-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (a large pink reddish rash(ring rash thing)around the injection site) and FATIGUE (tired) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported.). Concomitant products included MELOXICAM, COLECALCIFEROL (VITAMIN D3) and PARACETAMOL (TYLENOL) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced FATIGUE (tired). On 07-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (a large pink reddish rash(ring rash thing)around the injection site). On 30-Apr-2021, FATIGUE (tired) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (a large pink reddish rash(ring rash thing)around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       A Patient calling to report that she took the 1st dose of Moderna COVID-19 vaccine on 28Apr2021( Lot number: 009C21A Expiration Date: 15Oct2021) in her left upper arm muscle. She mentioned that first two days after the shot she was tired which was normal to her.  But on 07May2021 she started getting large pink reddish rash( like a ring rash thing) around the injection site. She wants to know if this is normal and if it is going to effect her 2nd dose that she is scheduled on 26May2021 and mentioned the rash has started to fade away.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Generalized Aching; chills; Feverish; Headache; This spontaneous case was reported by a physician and describes the occurrence of PAIN (Generalized Aching), CHILLS (chills), PYREXIA (Feverish) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ADALIMUMAB (HUMIRA) for Panuveitis.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Generalized Aching), CHILLS (chills), PYREXIA (Feverish) and HEADACHE (Headache). At the time of the report, PAIN (Generalized Aching), CHILLS (chills), PYREXIA (Feverish) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was not reported. No treatment medication was not reported
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: ache arm; mild tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (ache arm) and FATIGUE (mild tiredness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) UNK dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (ache arm) and FATIGUE (mild tiredness). At the time of the report, PAIN IN EXTREMITY (ache arm) and FATIGUE (mild tiredness) had resolved.            Patient recovered after half day. No treatment medications were provided.  No concomitant medications were provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Rash, Swelling
Clinical narrative: knot in neck; Rash on legs, arms, Knees and waist; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (knot in neck), RASH (Rash on legs, arms, Knees and waist) and INJECTION SITE PAIN (pain at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 029L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING (knot in neck), RASH (Rash on legs, arms, Knees and waist) and INJECTION SITE PAIN (pain at injection site). At the time of the report, SWELLING (knot in neck), RASH (Rash on legs, arms, Knees and waist) and INJECTION SITE PAIN (pain at injection site) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.     This case was linked to MOD-2021-030910 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Exposure via breast milk
Clinical narrative: Exposure via breast milk; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Exposure via breast milk) in a male patient of an unknown age exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 013L20A) , while the mother received the product for COVID-19 vaccination.     Concomitant product exposures included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] from 05-Dec-2020 to an unknown date for Pregnancy.   On 23-Dec-2020, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The mother's last menstrual period was on 15-May-2021 and the estimated date of delivery was 25-Feb-2021. On an unknown date, the patient was diagnosed with EXPOSURE VIA BREAST MILK (Exposure via breast milk). The patient was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. The vaginal delivery occurred on 24-Feb-2021, which was reported as Full-term. For neonate 1, the birth weight was 3560 grams (7lbs 14oz) with an APGAR score of 8 and 9 at (1, 5 minutes). The outcome was reported as Delivered NOS. At the time of the report, EXPOSURE VIA BREAST MILK (Exposure via breast milk) had resolved.            No concomitant medications provided. No treatment details were reported.   This case was linked to MOD-2021-010811, MOD-2021-010811 (Parent-Child Link).   See case MOD-2021-010811,MOD-2021-010811 for details regarding the Parent case.  Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Significant Follow up Appended - LMP & EDD updated
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Myalgia, Pyrexia
Clinical narrative: Fever of 100.5; Achiness all over which was pretty bad; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100.5) and MYALGIA (Achiness all over which was pretty bad) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 100.5) and MYALGIA (Achiness all over which was pretty bad). At the time of the report, PYREXIA (Fever of 100.5) and MYALGIA (Achiness all over which was pretty bad) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.5 (High) fever.         No concomitant medications were provided.  Patient stated symptoms occurred for about 2- 4  days.  Treatment medications were unknown.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events was not applicable.   This case was linked to MOD-2021-057694 (Patient Link).   Reporter did not allow further contact